Search Results

Drugs to Watch: Agents with New Mechanisms.

Subjects: DRUG therapy for schizophrenia; THERAPEUTIC use of monoclonal antibodies; HEPARIN antagonistsUNITED States. Food & Drug Administration

• Source: Formulary Watch. Apr2024, p6-9. 4p.

Record details

Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?

• Authors : Castle, David; Copolov, David; Singh, Bruce

Subjects: DRUG therapy for schizophrenia; HEALTH policy; BIOMARKERS

• Source: Australian & New Zealand Journal of Psychiatry. Mar2024, Vol. 58 Issue 3, p201-206. 6p.

Record details

Mending the Mind.

• Authors : Lieberman, Jeffrey

Subjects: SCHIZOPHRENIA treatment; DRUG therapy for schizophrenia; MINDFULNESS

• Source: Psychology Today. May/Jun2023, Vol. 56 Issue 3, p32-37. 6p.

Record details

Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice.

• Authors : Fraguas, David; Almenta Gallego, David; Arques-Egea, Sergio

Subjects: DRUG therapy for schizophrenia; CONSENSUS (Social sciences); ARIPIPRAZOLESPAIN

• Source: International Journal of Psychiatry in Clinical Practice. Mar2023, Vol. 27 Issue 1, p82-91. 10p.

Record details

Matrix metalloproteinase-3 serum levels in schizophrenic patients.

• Authors : Ordak, Michal; Libman-Sokolowska, Malgorzata; Nasierowski, Tadeusz

Subjects: DRUG therapy for schizophrenia; MATRIX metalloproteinases; SEX distribution

• Source: International Journal of Psychiatry in Clinical Practice. Mar2023, Vol. 27 Issue 1, p1-7. 7p.

Record details

CBTp for people with treatment refractory schizophrenia on clozapine: a systematic review and meta-analysis.

• Authors : Todorovic, Aleksandar; Lal, Sweta; Dark, Frances

Subjects: DRUG therapy for schizophrenia; ONLINE information services; CINAHL database

• Source: Journal of Mental Health. Feb2023, Vol. 32 Issue 1, p321-328. 8p. 1 Diagram, 1 Chart, 2 Graphs.

Record details

Side effects of clozapine in older adults with treatment‐resistant schizophrenia compared to younger adults.

• Authors : Groenewald, Floor C. E. (AUTHOR); Kok, Rob M. (AUTHOR)

Subjects: DRUG therapy for schizophrenia; ANESTHESIA; NAUSEANETHERLANDS

• Source: International Journal of Geriatric Psychiatry. Jan2024, Vol. 39 Issue 1, p1-8. 8p.

Record details

Antipsychotics and the risk of diabetes and death among adults with serious mental illnesses.

• Authors : Poulos, Jason (AUTHOR); Normand, Sharon-Lise T. (AUTHOR); Zelevinsky, Katya (AUTHOR)

Subjects: MORTALITY risk factors; DRUG therapy for schizophrenia; CONFIDENCE intervalsUNITED States

• Source: Psychological Medicine. Dec2023, Vol. 53 Issue 16, p7677-7684. 8p.

Record details

Antiviral treatment in schizophrenia: a randomized pilot PET study on the effects of valaciclovir on neuroinflammation.

• Authors : Jonker, Iris (AUTHOR); Doorduin, Janine (AUTHOR); Knegtering, Henderikus (AUTHOR)

Subjects: DRUG therapy for schizophrenia; FRONTAL lobe; PARIETAL lobeNETHERLANDS

• Source: Psychological Medicine. Nov2023, Vol. 53 Issue 15, p7087-7095. 9p.

Record details

Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review.

• Authors : Baumann, Pierre; Bauknecht, Philipp; Kuzin, Maxim

Subjects: DRUG therapy for schizophrenia; ONLINE information services; ARIPIPRAZOLE

• Source: International Journal of Psychiatry in Clinical Practice. Nov2023, Vol. 27 Issue 4, p367-384. 18p.

Record details